Access to Medicines
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines
MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions
Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is
MSF warns governments are failing to test, treat and prevent TB in children
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
